+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Non-Invasive Liver Monitor Market by Test Types, Technology, Application, End-User, Patient Type, Targeted Diseases - Global Forecast 2025-2030- Product Image
Non-Invasive Liver Monitor Market by Test Types, Technology, Application, End-User, Patient Type, Targeted Diseases - Global Forecast 2025-2030- Product Image
Sale

Non-Invasive Liver Monitor Market by Test Types, Technology, Application, End-User, Patient Type, Targeted Diseases - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • March 2025
  • Region: Global
  • 360iResearch™
  • ID: 6055072
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Non-Invasive Liver Monitor Market grew from USD 8.04 billion in 2024 to USD 8.57 billion in 2025. It is expected to continue growing at a CAGR of 6.98%, reaching USD 12.05 billion by 2030.

Non-invasive liver monitoring has emerged as a transformative force in modern healthcare, offering clinicians a safer and more patient-friendly alternative to traditional liver assessments. In an era where precision and efficacy are paramount, the integration of innovative technologies has redefined diagnostic protocols and enhanced patient care. The evolution of this market is underpinned by rigorous scientific research, advances in imaging techniques, and a growing preference for risk-averse diagnostic tools. Today, decision-makers are witnessing a convergence of breakthroughs that not only streamline clinical workflows but also open avenues for early disease detection. The solidity of these emerging methods has positioned non-invasive liver monitors as indispensable in the spectrum of hepatic disease management, transforming them from niche solutions into mainstream diagnostic assets. This report delves into the strategic innovations and value propositions that are reshaping the paradigms of liver health assessment, setting the stage for a new era in medical diagnostics.

Through this analysis, stakeholders gain a comprehensive view of market dynamics, enabling informed decision-making and sustainable growth strategies. It is clear that as technology evolves, so too does the ability to detect, monitor, and ultimately manage liver conditions with unprecedented accuracy and safety.

Transformative Shifts Redefining the Non-Invasive Liver Monitoring Landscape

The traditional boundaries of liver monitoring are rapidly expanding, thanks to a series of transformative shifts that have upended conventional practices. Rapid technological progress, reinforced by robust research and clinical validation, has triggered a paradigm shift in the landscape of liver diagnostics. Emerging innovations have streamlined processes, reduced invasiveness, and enhanced diagnostic accuracy, critically influencing how healthcare professionals perceive and manage hepatic diseases.

Advancements in imaging modalities and biomarker analysis have dramatically bolstered the precision of liver monitoring tools. Strategies that were once the exclusive domain of high-risk invasive methods are now being challenged by cutting-edge techniques that integrate computed tomography-based approaches, magnetic resonance elastography, near-infrared spectroscopy, advanced serum biomarker panels and scoring systems, and ultrasound elastography. This evolution reflects a broader trend across medical diagnostics, where the integration of multiple technologies not only optimizes diagnostic clarity but also ensures that the patient's experience is significantly improved. As these technologies converge, they offer more robust, multimodal insights that empower clinicians to customize treatment strategies with greater confidence. This dynamic interplay of innovation and clinical demand underscores a market trajectory that is moving towards enhanced accuracy, reduced patient discomfort, and, ultimately, improved clinical outcomes.

Key Segmentation Insights Driving Market Growth and Innovation

An in-depth analysis of the market reveals that segmentation plays a crucial role in understanding the full spectrum of non-invasive liver monitoring solutions. Observations based on test types distinguish between blood-based biomarker tests and imaging-based tests, ensuring that clinicians have access to diverse diagnostic perspectives. In terms of technology, the market is characterized by a robust analysis of computed tomography-based techniques, magnetic resonance elastography, near-infrared spectroscopy, serum biomarker panels and scoring, and ultrasound elastography. Each of these modalities contributes unique advantages that intersect effectively with the clinical demands of hepatic monitoring.

Exploring the application dimension, market studies have delved into areas such as disease staging and monitoring, early disease diagnosis, and post-surgery monitoring. Such comprehensive insights allow practitioners to tailor their choices based on the intricacies of disease progression and patient management. Similarly, a nuanced examination of end-users, including diagnostic centers, hospitals and clinics, and research institutions, underscores the multifaceted adoption of non-invasive liver monitoring techniques across different care settings. The segmentation further extends into patient type classifications, covering adults, geriatrics, and pediatric groups, and ensuring that the diagnostic tools cater to a broad demographic spectrum. Finally, a detailed review of targeted diseases including cirrhosis, fatty liver disease, hepatitis, and liver fibrosis - with particular attention to the subdivisions within hepatitis, namely hepatitis B and hepatitis C - synthesizes how market players can better allocate resources and tailor innovative solutions that meet the precise needs of diverse patient populations. These segmentation insights are indispensable for navigating the intricate market landscape and propelling future innovation.

Based on Test Types, market is studied across Blood-Based Biomarker Tests and Imaging-Based Tests.

Based on Technology, market is studied across Computed Tomography (CT)-Based Techniques, Magnetic Resonance Elastography (MRE), Near-Infrared Spectroscopy (NIRS), Serum Biomarker Panels & Scoring, and Ultrasound Elastography.

Based on Application, market is studied across Disease Staging & Monitoring, Early Disease Diagnosis, and Post-Surgery Monitoring.

Based on End-User, market is studied across Diagnostic Centers, Hospitals & Clinics, and Research Institutions.

Based on Patient Type, market is studied across Adult, Geriatric, and Pediatric.

Based on Targeted Diseases, market is studied across Cirrhosis, Fatty Liver Disease, Hepatitis, and Liver Fibrosis. The Hepatitis is further studied across Hepatitis B and Hepatitis C.

Regional Analysis Highlighting Global Market Dynamics

The market’s evolution is not only driven by technological and clinical advances but is also intricately linked to diverse regional economic and healthcare dynamics. The Americas play a pivotal role by showcasing rapid adoption of non-invasive liver monitoring solutions coupled with robust healthcare infrastructure and active clinical research. In this region, a combination of technological readiness and strong investment in healthcare advancements underpins the accelerated uptake of innovative diagnostics.

In contrast, the Europe, Middle East & Africa region presents a unique blend of mature healthcare systems and emerging markets, where regulatory frameworks and patient-centric care models fuel progressive adoption. Here, the convergence of health policy reforms with burgeoning research initiatives has facilitated a balanced growth environment that prioritizes both innovation and accessibility. Meanwhile, the Asia-Pacific region continues to be a hotbed of rapid technological advancements and increased healthcare spending, where governments and private sectors alike are investing significantly in modern healthcare infrastructure. The transformative potential of non-invasive liver monitoring is further amplified by the region’s demographic trends and strategic emphasis on reducing healthcare burdens through early diagnosis and intervention. Through careful regional analysis, stakeholders are better positioned to understand the variability in market demands and tailor their strategic initiatives to optimize regional performance.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Insights on Leading Companies Shaping the Market Landscape

The non-invasive liver monitor market is characterized by a competitive landscape with prominent companies driving innovation and setting new benchmarks for excellence. Noteworthy players such as Abbott Laboratories, Alpinion Medical Systems USA Inc., and Bruker Corporation GmbH are at the forefront of technological innovation, investing heavily in R&D to deliver state-of-the-art diagnostic solutions. Leaders including Canon Medical Systems Corporation, Chison Medical Imaging Co., Ltd., and Clarius Mobile Health, Inc. are also contributing significantly by continually refining imaging and detection capabilities that enhance clinical outcomes.

The industry’s growth is further bolstered by key market influencers like Echosens S.A. and Esaote S.p.A., which have established themselves as trusted names in liver monitoring diagnostics. Global giants such as F. Hoffmann-La Roche AG, Fujifilm Holdings Corporation, and GE HealthCare Technologies Inc. bring their well-renowned expertise and expansive market reach to the table, influencing the dynamics with a steady influx of innovative technologies. Additional insights are provided by trailblazers like Hologic, Inc., iLiv Diagnostics Inc., and Konica Minolta, Inc. whose strategic initiatives continue to redefine industry standards. Other significant contributors such as Koninklijke Philips N.V., Mindray Medical International Limited, Perspectum Diagnostics Ltd., Quibim, and Randox Laboratories Ltd. have been pivotal in pushing the envelope in terms of diagnostic efficiency and accuracy.

As the market consolidates its technological prowess, companies like Resonance Health Limited, Resoundant, Inc., Samsung Medison Co., Ltd., Siemens Healthcare Private Limited, Supersonic Imagine S.A., and Wuxi HISKY Medical Technologies Co., Ltd. collectively fortify the market landscape with a combination of inclusive product portfolios and relentless innovation. Their coordinated efforts not only reaffirm the market’s depth but also catalyze broader shifts towards enhanced patient care and diagnostic precision.

The report delves into recent significant developments in the Non-Invasive Liver Monitor Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alpinion Medical Systems USA Inc., Bruker Corporation GmbH, Canon Medical Systems Corporation, Chison Medical Imaging Co., Ltd., Clarius Mobile Health, Inc., Echosens S.A., Esaote S.p.A., F. Hoffmann-La Roche AG, Fujifilm Holdings Corporation, GE HealthCare Technologies Inc., Hologic, Inc., iLiv Diagnostics Inc., Konica Minolta, Inc., Koninklijke Philips N.V., Mindray Medical International Limited, Perspectum Diagnostics Ltd., Quibim, Randox Laboratories Ltd., Resonance Health Limited, Resoundant, Inc., Samsung Medison Co., Ltd., Siemens Healthcare Private Limited, Supersonic Imagine S.A., and Wuxi HISKY Medical Technologies Co., Ltd..

Actionable Recommendations for Industry Leaders to Strategize Effective Growth

Industry leaders are encouraged to consider a multifaceted approach when strategizing for future growth in the non-invasive liver monitor market. It is crucial to continually bolster research and development efforts, aligning investment with emerging technologies that promise enhanced diagnostic accuracy and greater patient safety. Organizations should focus on integrating cutting-edge imaging techniques and biomarker analyses, which together can drive the evolution of liver monitoring diagnostics. Emphasizing the adoption of complementary modalities ensures that healthcare providers can offer tailored, holistic diagnostic solutions.

Leaders are advised to further enhance cross-disciplinary collaborations by partnering with academic institutions and research centers to advance the scientific validation of these technologies. By targeting key demographic segments based on patient age and disease characteristics, companies can more effectively align product development with evolving clinical needs. Additionally, maintaining a proactive stance on regulatory compliance and quality assurance is essential in building trust among clinicians and patient communities alike. With rising awareness around liver health, engaging in strategic marketing initiatives that communicate both the clinical and economic benefits of non-invasive diagnostics can yield significant competitive advantages. By staying attuned to regional market dynamics and leveraging insights from segmented data, industry leaders are well positioned to pioneer innovations that not only address current market demands but also anticipate future trends.

Summarizing the Strategic Trajectory in Liver Diagnostics

The market for non-invasive liver monitoring is evolving at a brisk pace, driven by innovations that significantly improve diagnostic efficacy and patient outcomes. This comprehensive analysis has traced the progression of key technological advancements and provided granular insights into market segmentation, regional performance, and competitive dynamics. Each facet of the market, from test methodologies and technological enhancements to targeted applications and end-user focus, contributes to a robust and resilient industry landscape. As the market matures, the integration of advanced diagnostic tools promises to redefine patient care and expand the horizons of liver healthcare management.

In summary, the ever-changing principles of clinical diagnostics supported by transformative technology are setting new standards, ensuring that the focus remains on improved accuracy, efficiency, and patient-centric care. The collective insights presented in this report lay a strong foundation for understanding both current trends and future opportunities in the non-invasive liver monitor space.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing aging population globally necessitating advanced healthcare monitoring tools
5.1.1.2. Growing patient acceptance of diagnostic procedures due to reduced discomfort and associated risks
5.1.1.3. Government initiatives and funding support aimed at improving liver disease diagnosis and treatment
5.1.2. Restraints
5.1.2.1. High capital investment for purchasing and implementing advanced non-invasive liver monitoring systems
5.1.3. Opportunities
5.1.3.1. Expansion of telemedicine and remote patient monitoring enabled by digital health trends
5.1.3.2. Collaborative partnerships between tech companies and healthcare providers promoting technology integration
5.1.4. Challenges
5.1.4.1. High production and supply chain issues ensuring quality control for non-invasive liver monitoring devices
5.2. Market Segmentation Analysis
5.2.1. Test Types: Utilization of blood-based biomarker tests for their rapid turnaround time, cost-effectiveness
5.2.2. Targeted Diseases: Growing of fatty liver disease due to obesity and alcohol consumption
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Non-Invasive Liver Monitor Market, by Test Types
6.1. Introduction
6.2. Blood-Based Biomarker Tests
6.3. Imaging-Based Tests
7. Non-Invasive Liver Monitor Market, by Technology
7.1. Introduction
7.2. Computed Tomography (CT)-Based Techniques
7.3. Magnetic Resonance Elastography (MRE)
7.4. Near-Infrared Spectroscopy (NIRS)
7.5. Serum Biomarker Panels & Scoring
7.6. Ultrasound Elastography
8. Non-Invasive Liver Monitor Market, by Application
8.1. Introduction
8.2. Disease Staging & Monitoring
8.3. Early Disease Diagnosis
8.4. Post-Surgery Monitoring
9. Non-Invasive Liver Monitor Market, by End-User
9.1. Introduction
9.2. Diagnostic Centers
9.3. Hospitals & Clinics
9.4. Research Institutions
10. Non-Invasive Liver Monitor Market, by Patient Type
10.1. Introduction
10.2. Adult
10.3. Geriatric
10.4. Pediatric
11. Non-Invasive Liver Monitor Market, by Targeted Diseases
11.1. Introduction
11.2. Cirrhosis
11.3. Fatty Liver Disease
11.4. Hepatitis
11.4.1. Hepatitis B
11.4.2. Hepatitis C
11.5. Liver Fibrosis
12. Americas Non-Invasive Liver Monitor Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Non-Invasive Liver Monitor Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Non-Invasive Liver Monitor Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Scenario Analysis
15.3.1. Samaritan Family Health Center launch new non-invasive FibroScan service enhances liver health diagnostics
15.3.2. Legacy MD launch non-invasive liver testing with Fibroscan
15.3.3. Quibim launch AI-powered non-invasive liver monitor
15.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. NON-INVASIVE LIVER MONITOR MARKET MULTI-CURRENCY
FIGURE 2. NON-INVASIVE LIVER MONITOR MARKET MULTI-LANGUAGE
FIGURE 3. NON-INVASIVE LIVER MONITOR MARKET RESEARCH PROCESS
FIGURE 4. NON-INVASIVE LIVER MONITOR MARKET SIZE, 2024 VS 2030
FIGURE 5. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2024 VS 2030 (%)
FIGURE 9. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 11. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 13. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 15. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 17. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 18. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2024 VS 2030 (%)
FIGURE 19. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 20. AMERICAS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 21. AMERICAS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 22. UNITED STATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 23. UNITED STATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 24. ASIA-PACIFIC NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 25. ASIA-PACIFIC NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 28. NON-INVASIVE LIVER MONITOR MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 29. NON-INVASIVE LIVER MONITOR MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. NON-INVASIVE LIVER MONITOR MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. NON-INVASIVE LIVER MONITOR MARKET DYNAMICS
TABLE 7. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY BLOOD-BASED BIOMARKER TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY IMAGING-BASED TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT)-BASED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY MAGNETIC RESONANCE ELASTOGRAPHY (MRE), BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY NEAR-INFRARED SPECTROSCOPY (NIRS), BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY SERUM BIOMARKER PANELS & SCORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY ULTRASOUND ELASTOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY DISEASE STAGING & MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY EARLY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY POST-SURGERY MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY CIRRHOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY FATTY LIVER DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS B, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS C, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY LIVER FIBROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 58. CANADA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 59. CANADA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. CANADA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. CANADA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. CANADA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 63. CANADA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 64. CANADA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 65. MEXICO NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 66. MEXICO NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 67. MEXICO NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. MEXICO NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. MEXICO NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 70. MEXICO NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 71. MEXICO NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 93. AUSTRALIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 94. AUSTRALIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 95. CHINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 96. CHINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 97. CHINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. CHINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. CHINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 100. CHINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 101. CHINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 102. INDIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 103. INDIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 104. INDIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. INDIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. INDIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 107. INDIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 108. INDIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. INDONESIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 114. INDONESIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 115. INDONESIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 116. JAPAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 117. JAPAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 118. JAPAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. JAPAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. JAPAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 121. JAPAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 122. JAPAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 123. MALAYSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. MALAYSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. MALAYSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. MALAYSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 128. MALAYSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 129. MALAYSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 130. PHILIPPINES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 131. PHILIPPINES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 132. PHILIPPINES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. PHILIPPINES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. PHILIPPINES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 135. PHILIPPINES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 136. PHILIPPINES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 137. SINGAPORE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 138. SINGAPORE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. SINGAPORE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. SINGAPORE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 142. SINGAPORE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 143. SINGAPORE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 144. SOUTH KOREA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 145. SOUTH KOREA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. SOUTH KOREA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 149. SOUTH KOREA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 150. SOUTH KOREA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 151. TAIWAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. TAIWAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 156. TAIWAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 157. TAIWAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 158. THAILAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 159. THAILAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. THAILAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. THAILAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. THAILAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 163. THAILAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 164. THAILAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 165. VIETNAM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. VIETNAM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 170. VIETNAM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 171. VIETNAM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 180. DENMARK NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 181. DENMARK NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 182. DENMARK NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. DENMARK NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. DENMARK NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 185. DENMARK NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 186. DENMARK NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 187. EGYPT NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 188. EGYPT NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 189. EGYPT NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. EGYPT NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 191. EGYPT NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 192. EGYPT NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 193. EGYPT NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 194. FINLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 195. FINLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 196. FINLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. FINLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 198. FINLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 199. FINLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 200. FINLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 201. FRANCE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 202. FRANCE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 203. FRANCE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. FRANCE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 205. FRANCE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 206. FRANCE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 207. FRANCE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 208. GERMANY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 209. GERMANY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 210. GERMANY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. GERMANY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 212. GERMANY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 213. GERMANY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 214. GERMANY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 219. ISRAEL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 220. ISRAEL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 221. ISRAEL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 222. ITALY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 223. ITALY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 224. ITALY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. ITALY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 226. ITALY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 227. ITALY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 228. ITALY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 235. NETHERLANDS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 243. NORWAY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 244. NORWAY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 245. NORWAY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. NORWAY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 247. NORWAY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 248. NORWAY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 249. NORWAY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 250. POLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 251. POLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 252. POLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. POLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 254. POLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 255. POLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 256. POLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 257. QATAR NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 258. QATAR NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 259. QATAR NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. QATAR NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 261. QATAR NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 262. QATAR NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 263. QATAR NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 285. SPAIN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 286. SPAIN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 287. SPAIN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 288. SPAIN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 289. SPAIN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 290. SPAIN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 291. SPAIN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 303. SWITZERLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 304. SWITZERLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 305. SWITZERLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 306. TURKEY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 307. TURKEY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 308. TURKEY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 309. TURKEY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 310. TURKEY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 311. TURKEY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 312. TURKEY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 320. UNITED KINGDOM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 321. UNITED KINGDOM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 322. UNITED KINGDOM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 324. UNITED KINGDOM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 325. UNITED KINGDOM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES

Companies Mentioned

  • Abbott Laboratories
  • Alpinion Medical Systems USA Inc.
  • Bruker Corporation GmbH
  • Canon Medical Systems Corporation
  • Chison Medical Imaging Co., Ltd.
  • Clarius Mobile Health, Inc.
  • Echosens S.A.
  • Esaote S.p.A.
  • F. Hoffmann-La Roche AG
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hologic, Inc.
  • iLiv Diagnostics Inc.
  • Konica Minolta, Inc.
  • Koninklijke Philips N.V.
  • Mindray Medical International Limited
  • Perspectum Diagnostics Ltd.
  • Quibim
  • Randox Laboratories Ltd.
  • Resonance Health Limited
  • Resoundant, Inc.
  • Samsung Medison Co., Ltd.
  • Siemens Healthcare Private Limited
  • Supersonic Imagine S.A.
  • Wuxi HISKY Medical Technologies Co., Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages194
PublishedMarch 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 8.57 Billion
Forecasted Market Value ( USD ) by 2030 $ 12.05 Billion
Compound Annual Growth Rate6.9%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Bilirubin Meters Market Report 2024 - Product Image

Bilirubin Meters Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Medical Electronics Market by Product Type, Component, Application, End-User - Global Forecast 2025-2030 - Product Image

Medical Electronics Market by Product Type, Component, Application, End-User - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Cancer Biopsy Market by Product, Type, Indication - Global Forecast 2025-2030 - Product Image

Cancer Biopsy Market by Product, Type, Indication - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Biopsy Devices Market Global Report by Product, Application, Technology, End-User, Countries and Company Analysis 2025-2033 - Product Image

Biopsy Devices Market Global Report by Product, Application, Technology, End-User, Countries and Company Analysis 2025-2033

  • Report
  • 215 Pages
  • Global
From
Occlusion Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Occlusion Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.